The INMARE consortium will unify multidisciplinary expertise and facilities, including advanced technologies to access and sample unique marine biodiversity hot-spots; state-of-the art technologies for construction of metagenomic libraries; innovative enzyme screening assays and platforms; cutting-edge sequence annotation pipelines and bioinformatics resources; high-end activity screening technology; bioanalytical and bioprocess engineering facilities and expertise, nanoparticle-biocatalysts; high-quality protein crystallization and structural analysis facilities and experts in IP management for biotechnology.

The companies involved in the project are market leaders in enzyme production and biocatalysis to more efficiently deliver safer (pharmaceuticals, cheaper (agriculture) and biobased (biopolymers) products. In addition, all participating companies feel responsible and committed to render chemical processes greener.

Further industrial partners involved, have impressive track records in natural products discovery for biomedical, especially anti-cancer (with the production of the first antitumor medicine from marine resources), environmental cleanup applications and public dissemination of science and in increasing the public awareness and interest in research.